• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Combined Use of Frontline Tri-Act and NexGard Spectra

September 26, 2018
Natalie Stilwell, DVM, MS, PhD

A recent study evaluated efficacy of the 2 drugs in an endemic region for canine Leishmania and Dirofilaria immitis infections.

Researchers in Italy recently examined safety and efficacy associated with combined use of 2 new antiparasitic products (Frontline Tri-Act and NexGard Spectra, both manufactured by Merial, now part of Boehringer Ingelheim) in client-owned dogs. The authors aimed to determine an effective prophylactic regimen against ectoparasites, endoparasites, and vector-borne diseases in endemic regions. Intestinal nematode infection is common in Italy, and canine leishmaniasis and dirofilariasis have overlapping distributions.

Study Design

Apparently healthy, client-owned dogs in endemic regions of southern Italy underwent initial screening for internal and external parasites and vector-borne diseases.

RELATED:

  • Flea, Tick Products Linked to Neurologic Adverse Events
  • Can Permethrin-treated Clothing Prevent Tick Bites?

Assessment included:

  • physical examination
Advertisement
  • fecal examination
  • CBC
  • Modified Knott’s test for D immitis
  • Rapid ELISA for Leishmania, Anaplasma, Borrelia, Ehrlichia, and D immitis

Frontline Tri-Act (fipronil/permethrin) and NexGard Spectra (afoxolaner/milbemycin oxime) were then administered every 28 days for 6 months, and diagnostic tests were repeated throughout the study to re-evaluate parasite burdens.

Results

Thirty-seven dogs with a mean age of 3.6 years and weight range of 3.4 to 32 kg completed the study. All dogs either lived in single-pet households or in 1 of 3 kennels consisting of multiple hunting dogs.

No adverse events were observed from concurrent administration of Frontline Tri-Act and NexGard Spectra, and all biological parameters, including weight, body condition, and hematological parameters, remained within physiological limits throughout the study.

At the beginning of the study, 19% and 84% of pet and hunting dogs, respectively, were infected with gastrointestinal nematodes, mostly consisting of Trichuris vulpis and Ancylostomatidae. Fourteen days after the first administration of Frontline Tri-Act and NexGard Spectra, 40% of hunting dogs continued to shed eggs. All pet dogs remained nematode-free from Day 14 until the end of the study, while several hunting dogs continued to shed hookworm eggs for the study’s duration.

Nineteen percent of pet dogs and 84% of hunting dogs were infested with fleas at the beginning of the study, while 98% of all dogs were flea-negative 1 day after Frontline Tri-Act and NexGard Spectra administration. Four weeks later, 28% of hunting dogs again had flea burdens, but the authors noted most fleas were dead or moribund.

Ticks were initially observed on 6% and 12% of pet and hunting dogs, respectively, but dogs were all tick-free from Day 14 until the end of the study. While 6 hunting dogs were serologically positive for Leishmania at the beginning and end of the study, all other dogs tested negative for Leishmania, Anaplasma, Borrelia, Ehrlichia, and D immitis.

Final Thoughts

The study’s authors deemed that combined use of Frontline Tri-Act and NexGard Spectra for 6 months was safe and effective against endo- and ecoparasite infections in client-owned dogs. Although all dogs appeared clinically healthy, many were infected with intestinal parasites on initial examination. Also, hookworm infections were particularly persistent in kennel-housed dogs, which may necessitate milbemycin oxime dosing every 2 weeks for initial control, according to the authors.

Dr. Stilwell received her DVM from Auburn University, followed by a MS in fisheries and aquatic sciences and a PhD in veterinary medical sciences from the University of Florida. She provides freelance medical writing and aquatic veterinary consulting services through her business, Seastar Communications and Consulting.

Related Content:

Parasitology
AHS urges veterinarians to submit data for 2022 Heartworm Incidence Map
AHS urges veterinarians to submit data for 2022 Heartworm Incidence Map
Top dvm360 podcasts of 2022: #3
Top dvm360 podcasts of 2022: #3
Common errors in parasite fecal diagnostics
Common errors in parasite fecal diagnostics

Advertisement

Latest News

Comparing treatments for restoring the skin barrier in atopic dogs

Increasing efficiency and productivity in uncertain times

AAVMC awards almost $100,000 in diversity scholarships

News wrap-up: This week’s headlines, plus Maryland Zoo welcomes baby addra gazelle

View More Latest News
Advertisement